
Senti Biosciences, Inc.
SNTIHealthcare|Biotechnology|US
$0.16
-0.00 (-2.74%)
Cash / Share
$0.21
Next Earnings Report
Nov 12, 2026
EPS est. -$0.21 · Revenue est. $15.9K
Financing Filings (last 12 months)
6
Shelf registrations / offering prospectuses — latest Sep 24, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Awaiting Results (1)
Trials past primary completion date but still active — data readout may be imminent.
Feb 2026
P1
SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS
NCT06325748SEC Filings (109)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 27, 2026 | 8-K | Material event | DocumentIndex |
| Oct 26, 2026 | 8-K | Material event | DocumentIndex |
| Oct 15, 2026 | 8-K | Material event | DocumentIndex |
| Oct 13, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Oct 13, 2026 | 8-K | Material event | DocumentIndex |
| Sep 24, 2026 | EFFECT | DocumentIndex | |
| Sep 24, 2026 | DEFM14A | Proxy / shareholder vote | DocumentIndex |
| Sep 24, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Sep 24, 2026 | 8-K | Material event | DocumentIndex |
| Sep 24, 2026 | PRER14A | DocumentIndex | |
| Sep 22, 2026 | S-3/A | Shelf registration | DocumentIndex |
| Sep 11, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Sep 10, 2026 | S-3/A | Shelf registration | DocumentIndex |
| Sep 4, 2026 | PRER14A | DocumentIndex | |
| Sep 4, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Sep 4, 2026 | 8-K | Material event | DocumentIndex |
| Sep 2, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Sep 2, 2026 | 8-K | Material event | DocumentIndex |
| Aug 20, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Aug 20, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Jul 21, 2026 | ARS | Annual report to holders | DocumentIndex |
| Jul 21, 2026 | PREM14A | DocumentIndex | |
| Jul 16, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Jul 16, 2026 | S-3/A | Shelf registration | DocumentIndex |
| Jul 15, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Jul 15, 2026 | 8-K | Material event | DocumentIndex |
| Jun 18, 2026 | S-3 | Shelf registration | DocumentIndex |
| Jun 4, 2026 | D | DocumentIndex | |
| May 26, 2026 | 8-K | Material event | DocumentIndex |
| May 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 14, 2026 | 8-K | Material event | DocumentIndex |
| May 8, 2026 | 15-12G | DocumentIndex | |
| May 4, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| May 1, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| May 1, 2026 | 8-K | Material event | DocumentIndex |
| Apr 29, 2026 | EFFECT | DocumentIndex | |
| Apr 29, 2026 | EFFECT | DocumentIndex | |
| Apr 29, 2026 | EFFECT | DocumentIndex | |
| Apr 29, 2026 | EFFECT | DocumentIndex |